Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2008, Article ID 728763, 13 pages
http://dx.doi.org/10.1155/2008/728763
Research Article

Islet Specific Wnt Activation in Human Type II Diabetes

1Development and Aging Program, Burnham Institute for Medical Research, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA
2Department of Pediatrics, University of California San Diego, 9500 Gilman Dr, MC 0816, La Jolla, CA 92093, USA
3Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA
4Sanford Children's Health Research Center, Burnham Institute for Medical Research, 10901 N. Torrey Pines Road, CA 92037, USA

Received 3 June 2008; Accepted 7 October 2008

Academic Editor: Anjan Kowluru

Copyright © 2008 Seung-Hee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Porte Jr. and S. E. Kahn, “The key role of islet dysfunction in type II diabetes mellitus,” Clinical and Investigative Medicine, vol. 18, no. 4, pp. 247–254, 1995. View at Google Scholar
  2. V. Poitout, I. Briaud, C. Kelpe, and D. Hagman, “Gluco-lipotoxicity of the pancreatic beta cell,” Annales d'Endocrinologie, vol. 65, no. 1, pp. 37–41, 2004. View at Google Scholar
  3. J. E. Gunton, R. N. Kulkarni, S. Yim et al., “Loss of ARNT/HIF1ß mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes,” Cell, vol. 122, no. 3, pp. 337–349, 2005. View at Publisher · View at Google Scholar
  4. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes,” The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. View at Publisher · View at Google Scholar
  5. A. J. Chien and R. T. Moon, “WNTS and WNT receptors as therapeutic tools and targets in human disease processes,” Frontiers in Bioscience, vol. 12, no. 2, pp. 448–457, 2007. View at Publisher · View at Google Scholar
  6. L. L. S. Murphy and C. C. W. Hughes, “Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the Wnt/glycogen synthase kinase-3β pathway,” Journal of Immunology, vol. 169, no. 7, pp. 3717–3725, 2002. View at Google Scholar
  7. J. J. Heit, Å. A. Apelqvist, X. Gu et al., “Calcineurin/NFAT signalling regulates pancreatic ß-cell growth and function,” Nature, vol. 443, no. 7109, pp. 345–349, 2006. View at Publisher · View at Google Scholar
  8. R. S. Heller, D. S. Dichmann, J. Jensen et al., “Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation,” Developmental Dynamics, vol. 225, no. 3, pp. 260–270, 2002. View at Publisher · View at Google Scholar
  9. S. Papadopoulou and H. Edlund, “Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function,” Diabetes, vol. 54, no. 10, pp. 2844–2851, 2005. View at Publisher · View at Google Scholar
  10. L. C. Murtaugh, A. C. Law, Y. Dor, and D. A. Melton, “β-catenin is essential for pancreatic acinar but not islet development,” Development, vol. 132, no. 21, pp. 4663–4674, 2005. View at Publisher · View at Google Scholar
  11. T. Fujino, H. Asaba, M.-J. Kang et al., “Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 229–234, 2003. View at Publisher · View at Google Scholar
  12. P. W. Heiser, J. Lau, M. M. Taketo, P. L. Herrera, and M. Hebrok, “Stabilization of β-catenin impacts pancreas growth,” Development, vol. 133, no. 10, pp. 2023–2032, 2006. View at Publisher · View at Google Scholar
  13. I. C. Rulifson, S. K. Karnik, P. W. Heiser et al., “Wnt signaling regulates pancreatic ß cell proliferation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 15, pp. 6247–6252, 2007. View at Publisher · View at Google Scholar
  14. U. Dahl, A. Sjödin, and H. Semb, “Cadherins regulate aggregation of pancreatic β-cells in vivo,” Development, vol. 122, no. 9, pp. 2895–2902, 1996. View at Google Scholar
  15. A. D. Kohn and R. T. Moon, “Wnt and calcium signaling: β-catenin-independent pathways,” Cell Calcium, vol. 38, no. 3-4, pp. 439–446, 2005. View at Publisher · View at Google Scholar
  16. D. M. Lehman, K. J. Hunt, R. J. Leach et al., “Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans,” Diabetes, vol. 56, no. 2, pp. 389–393, 2007. View at Publisher · View at Google Scholar
  17. S. Cauchi, D. Meyre, C. Dina et al., “Transcription factor TCF7L2 genetic study in the French population: expression in human ß-cells and adipose tissue and strong association with type 2 diabetes,” Diabetes, vol. 55, no. 10, pp. 2903–2908, 2006. View at Publisher · View at Google Scholar
  18. L. J. Scott, L. L. Bonnycastle, C. J. Willer et al., “Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a finnish sample,” Diabetes, vol. 55, no. 9, pp. 2649–2653, 2006. View at Publisher · View at Google Scholar
  19. S. F. A. Grant, G. Thorleifsson, I. Reynisdottir et al., “Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes,” Nature Genetics, vol. 38, no. 3, pp. 320–323, 2006. View at Publisher · View at Google Scholar
  20. V. Lyssenko, R. Lupi, P. Marchetti et al., “Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes,” The Journal of Clinical Investigation, vol. 117, no. 8, pp. 2155–2163, 2007. View at Publisher · View at Google Scholar
  21. D. R. Laybutt, A. M. Preston, M. C. Åkerfeldt et al., “Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 752–763, 2007. View at Publisher · View at Google Scholar
  22. B. Tyrberg, K. A. Anachkov, S. A. Dib, J. Wang-Rodriguez, K.-H. Yoon, and F. Levine, “Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Oggl) in human type 2 diabetes,” BMC Endocrine Disorders, vol. 2, articel 2, pp. 1–10, 2002. View at Publisher · View at Google Scholar
  23. E. Hao, B. Tyrberg, P. Itkin-Ansari et al., “Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas,” Nature Medicine, vol. 12, no. 3, pp. 310–316, 2006. View at Publisher · View at Google Scholar
  24. P. Itkin-Ansari, C. Demeterco, S. Bossie et al., “PDX-1 and cell-cell contact act in synergy to promote d-cell development in a human pancreatic endocrine precursor cell line,” Molecular Endocrinology, vol. 14, no. 6, pp. 814–822, 2000. View at Publisher · View at Google Scholar
  25. C. H. Warden and J. S. Fisler, “Comparisons of diets used in animal models of high-fat feeding,” Cell Metabolism, vol. 7, no. 4, p. 277, 2008. View at Publisher · View at Google Scholar
  26. M. Saegusa, M. Hashimura, T. Kuwata, M. Hamano, and I. Okayasu, “Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells,” Laboratory Investigation, vol. 85, no. 6, pp. 768–779, 2005. View at Publisher · View at Google Scholar
  27. R. S. Heller, T. Klein, Z. Ling et al., “Expression of Wnt, Frizzled, sFRP, and DKK genes in adult human pancreas,” Gene Expression, vol. 11, no. 3-4, pp. 141–147, 2003. View at Publisher · View at Google Scholar
  28. J. Zhurinsky, M. Shtutman, and A. Ben-Ze'ev, “Plakoglobin and β-catenin: protein interactions, regulation and biological roles,” Journal of Cell Science, vol. 113, no. 18, pp. 3127–3139, 2000. View at Google Scholar
  29. N. Barker and H. Clevers, “Catenins, Wnt signaling and cancer,” BioEssays, vol. 22, no. 11, pp. 961–965, 2000. View at Publisher · View at Google Scholar
  30. P. S. Issack and E. B. Ziff, “Altered expression of helix-loop-helix transcriptional regulators and cyclin D1 in Wnt-1-transformed PC12 cells,” Cell Growth and Differentiation, vol. 9, no. 10, pp. 837–845, 1998. View at Google Scholar
  31. J. Rahier, R. M. Goebbels, and J. C. Henquin, “Cellular composition of the human diabetic pancreas,” Diabetologia, vol. 24, no. 5, pp. 366–371, 1983. View at Publisher · View at Google Scholar
  32. K. K. Papas, B. J. Hering, L. Gunther, M. J. Rappel, C. K. Colton, and E. S. Avgoustiniatos, “Pancreas oxygenation is limited during preservation with the two-layer method,” Transplantation Proceedings, vol. 37, no. 8, pp. 3501–3504, 2005. View at Publisher · View at Google Scholar
  33. V. W. Ding, R.-H. Chen, and F. McCormick, “Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling,” The Journal of Biological Chemistry, vol. 275, no. 42, pp. 32475–32481, 2000. View at Publisher · View at Google Scholar
  34. Y. Kawano and R. Kypta, “Secreted antagonists of the Wnt signalling pathway,” Journal of Cell Science, vol. 116, no. 13, pp. 2627–2634, 2003. View at Publisher · View at Google Scholar
  35. L. Baeyens, S. De Breuck, J. Lardon, J. K. Mfopou, I. Rooman, and L. Bouwens, “In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells,” Diabetologia, vol. 48, no. 1, pp. 49–57, 2005. View at Publisher · View at Google Scholar
  36. D. Gu, M.-S. Lee, T. Krahl, and N. Sarvetnick, “Transitional cells in the regenerating pancreas,” Development, vol. 120, no. 7, pp. 1873–1881, 1994. View at Google Scholar
  37. E. Bertelli and M. Bendayan, “Intermediate endocrine-acinar pancreatic cells in duct ligation conditions,” American Journal of Physiology, vol. 273, no. 5, pp. C1641–C1649, 1997. View at Google Scholar
  38. J. Lardon, N. Huyens, I. Rooman, and L. Bouwens, “Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas,” Virchows Archiv, vol. 444, no. 1, pp. 61–65, 2004. View at Publisher · View at Google Scholar
  39. D. Gu, M. Arnush, and N. Sarvetnick, “Endocrine/exocrine intermediate cells in streptozotocin-treated ins- IFN-γ transgenic mice,” Pancreas, vol. 15, no. 3, pp. 246–250, 1997. View at Google Scholar
  40. Y.-F. Guo, D.-H. Xiong, H. Shen et al., “Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study,” Journal of Medical Genetics, vol. 43, no. 10, pp. 798–803, 2006. View at Publisher · View at Google Scholar
  41. A. Kanazawa, S. Tsukada, A. Sekine et al., “Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes,” American Journal of Human Genetics, vol. 75, no. 5, pp. 832–843, 2004. View at Publisher · View at Google Scholar
  42. J. A. Noble, A. M. White, L. C. Lazzeroni et al., “A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes,” Diabetes, vol. 52, no. 6, pp. 1579–1582, 2003. View at Publisher · View at Google Scholar
  43. C. Demeterco, P. Itkin-Ansari, B. Tyrberg, L. P. Ford, R. A. Jarvis, and F. Levine, “c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 7, pp. 3475–3485, 2002. View at Publisher · View at Google Scholar
  44. D. R. Laybutt, G. C. Weir, H. Kaneto et al., “Overexpression of c-Myc in ß-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes,” Diabetes, vol. 51, no. 6, pp. 1793–1804, 2002. View at Publisher · View at Google Scholar
  45. A. J. Mikels and R. Nusse, “Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context,” PLoS Biology, vol. 4, no. 4, p. e115, 2006. View at Publisher · View at Google Scholar
  46. R.-H. Chen, W. V. Ding, and F. McCormick, “Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3β inhibition and activation of protein kinase C,” The Journal of Biological Chemistry, vol. 275, no. 23, pp. 17894–17899, 2000. View at Publisher · View at Google Scholar
  47. D. A. E. Cross, D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings, “Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B,” Nature, vol. 378, no. 6559, pp. 785–789, 1995. View at Publisher · View at Google Scholar
  48. A. S. Wagman, K. W. Johnson, and D. E. Bussiere, “Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes,” Current Pharmaceutical Design, vol. 10, no. 10, pp. 1105–1138, 2004. View at Publisher · View at Google Scholar
  49. E. Charpentier, R. M. Lavker, E. Acquista, and P. Cowin, “Plakoglobin suppresses epithelial proliferation and hair growth in vivo,” The Journal of Cell Biology, vol. 149, no. 2, pp. 503–519, 2000. View at Publisher · View at Google Scholar
  50. U. Gat, R. DasGupta, L. Degenstein, and E. Fuchs, “De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin,” Cell, vol. 95, no. 5, pp. 605–614, 1998. View at Publisher · View at Google Scholar
  51. B. O. Williams, G. D. Barish, M. W. Klymkowsky, and H. E. Varmus, “A comparative evaluation of β-catenin and plakoglobin signaling activity,” Oncogene, vol. 19, no. 50, pp. 5720–5728, 2000. View at Publisher · View at Google Scholar
  52. A. M. J. Shapiro, C. Ricordi, B. J. Hering et al., “International trial of the Edmonton protocol for islet transplantation,” The New England Journal of Medicine, vol. 355, no. 13, pp. 1318–1330, 2006. View at Publisher · View at Google Scholar
  53. H. Kaneto, A. Sharma, K. Suzuma et al., “Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation,” The Journal of Biological Chemistry, vol. 277, no. 15, pp. 12998–13006, 2002. View at Publisher · View at Google Scholar
  54. S. Pelengaris, B. Rudolph, and T. Littlewood, “Action of Myc in vivo—proliferation and apoptosis,” Current Opinion in Genetics & Development, vol. 10, no. 1, pp. 100–105, 2000. View at Publisher · View at Google Scholar
  55. F. Wang, M. Herrington, J. Larsson, and J. Permert, “The relationship between diabetes and pancreatic cancer,” Molecular Cancer, vol. 2, article 4, pp. 1–5, 2003. View at Publisher · View at Google Scholar
  56. L. C. Richardson and L. A. Pollack, “Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer,” Nature Clinical Practice Oncology, vol. 2, no. 1, pp. 48–53, 2005. View at Publisher · View at Google Scholar
  57. P. W. Heiser, D. A. Cano, L. Landsman et al., “Stabilization of ß-catenin induces pancreas tumor formation,” Gastroenterology, vol. 135, no. 4, pp. 1288–1300, 2008. View at Publisher · View at Google Scholar